

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 4.53055515 |
| 2 | DNA replication checkpoint (GO:0000076) | 4.49475360 |
| 3 | kinetochore organization (GO:0051383) | 4.18329009 |
| 4 | protein localization to kinetochore (GO:0034501) | 4.12192863 |
| 5 | kinetochore assembly (GO:0051382) | 4.11167341 |
| 6 | mitotic metaphase plate congression (GO:0007080) | 4.00596357 |
| 7 | DNA replication initiation (GO:0006270) | 3.97474659 |
| 8 | establishment of integrated proviral latency (GO:0075713) | 3.89343918 |
| 9 | CENP-A containing nucleosome assembly (GO:0034080) | 3.89273284 |
| 10 | spliceosomal snRNP assembly (GO:0000387) | 3.86650493 |
| 11 | maturation of SSU-rRNA (GO:0030490) | 3.82853426 |
| 12 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.79611051 |
| 13 | chromatin remodeling at centromere (GO:0031055) | 3.78604153 |
| 14 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.78203981 |
| 15 | ribosome assembly (GO:0042255) | 3.78129286 |
| 16 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.77344339 |
| 17 | protein maturation by protein folding (GO:0022417) | 3.76325260 |
| 18 | DNA strand elongation (GO:0022616) | 3.75561337 |
| 19 | spliceosomal complex assembly (GO:0000245) | 3.71069009 |
| 20 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.69105790 |
| 21 | ribosomal large subunit biogenesis (GO:0042273) | 3.63866664 |
| 22 | telomere maintenance via recombination (GO:0000722) | 3.60550668 |
| 23 | establishment of viral latency (GO:0019043) | 3.57155939 |
| 24 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.51415263 |
| 25 | negative regulation of ligase activity (GO:0051352) | 3.50282572 |
| 26 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.50282572 |
| 27 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.48099113 |
| 28 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.46995444 |
| 29 | regulation of mitochondrial translation (GO:0070129) | 3.46443966 |
| 30 | metaphase plate congression (GO:0051310) | 3.46401435 |
| 31 | DNA replication-independent nucleosome organization (GO:0034724) | 3.44147735 |
| 32 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.44147735 |
| 33 | ribosomal small subunit assembly (GO:0000028) | 3.44016339 |
| 34 | mitotic recombination (GO:0006312) | 3.42967413 |
| 35 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.41204812 |
| 36 | protein localization to chromosome, centromeric region (GO:0071459) | 3.35357586 |
| 37 | intra-S DNA damage checkpoint (GO:0031573) | 3.31732895 |
| 38 | mitotic chromosome condensation (GO:0007076) | 3.31550353 |
| 39 | telomere maintenance via telomere lengthening (GO:0010833) | 3.29315004 |
| 40 | DNA strand renaturation (GO:0000733) | 3.28491121 |
| 41 | nuclear pore organization (GO:0006999) | 3.28017155 |
| 42 | mismatch repair (GO:0006298) | 3.26359670 |
| 43 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.24299269 |
| 44 | mitotic nuclear envelope disassembly (GO:0007077) | 3.22769804 |
| 45 | regulation of translational termination (GO:0006449) | 3.22146213 |
| 46 | DNA unwinding involved in DNA replication (GO:0006268) | 3.21603966 |
| 47 | translational termination (GO:0006415) | 3.20970573 |
| 48 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.20886875 |
| 49 | viral transcription (GO:0019083) | 3.20453066 |
| 50 | pseudouridine synthesis (GO:0001522) | 3.19175664 |
| 51 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.18754934 |
| 52 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.17217144 |
| 53 | nucleobase biosynthetic process (GO:0046112) | 3.16506438 |
| 54 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.14655020 |
| 55 | viral mRNA export from host cell nucleus (GO:0046784) | 3.14474702 |
| 56 | purine nucleobase biosynthetic process (GO:0009113) | 3.14364941 |
| 57 | spindle checkpoint (GO:0031577) | 3.14063720 |
| 58 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.12064640 |
| 59 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.10108349 |
| 60 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.10108349 |
| 61 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.09643818 |
| 62 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.09643818 |
| 63 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.09643818 |
| 64 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.08654546 |
| 65 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.08390632 |
| 66 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.08078917 |
| 67 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.08078917 |
| 68 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.07483994 |
| 69 | histone exchange (GO:0043486) | 3.04358546 |
| 70 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.03885323 |
| 71 | meiotic chromosome segregation (GO:0045132) | 3.02555945 |
| 72 | ribosomal small subunit biogenesis (GO:0042274) | 3.01743086 |
| 73 | mitotic spindle checkpoint (GO:0071174) | 3.01623938 |
| 74 | rRNA modification (GO:0000154) | 3.00455539 |
| 75 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.99093846 |
| 76 | establishment of chromosome localization (GO:0051303) | 2.98755002 |
| 77 | ribosome biogenesis (GO:0042254) | 2.98452059 |
| 78 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.98186854 |
| 79 | spindle assembly checkpoint (GO:0071173) | 2.97634670 |
| 80 | IMP biosynthetic process (GO:0006188) | 2.97256251 |
| 81 | negative regulation of chromosome segregation (GO:0051985) | 2.97155455 |
| 82 | formation of translation preinitiation complex (GO:0001731) | 2.96268573 |
| 83 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.94604674 |
| 84 | negative regulation of sister chromatid segregation (GO:0033046) | 2.94604674 |
| 85 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.94604674 |
| 86 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.94604674 |
| 87 | telomere organization (GO:0032200) | 2.92896612 |
| 88 | telomere maintenance (GO:0000723) | 2.92689572 |
| 89 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.92627266 |
| 90 | termination of RNA polymerase III transcription (GO:0006386) | 2.92627266 |
| 91 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.91979599 |
| 92 | pentose-phosphate shunt (GO:0006098) | 2.91620230 |
| 93 | mitotic spindle assembly checkpoint (GO:0007094) | 2.91329303 |
| 94 | mitotic sister chromatid segregation (GO:0000070) | 2.90672685 |
| 95 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.89920474 |
| 96 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.89611553 |
| 97 | protein K6-linked ubiquitination (GO:0085020) | 2.88382662 |
| 98 | positive regulation of ligase activity (GO:0051351) | 2.88159500 |
| 99 | protein targeting to mitochondrion (GO:0006626) | 2.86342509 |
| 100 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.86168613 |
| 101 | nuclear pore complex assembly (GO:0051292) | 2.86133787 |
| 102 | NADPH regeneration (GO:0006740) | 2.85652890 |
| 103 | membrane disassembly (GO:0030397) | 2.83882055 |
| 104 | nuclear envelope disassembly (GO:0051081) | 2.83882055 |
| 105 | mitotic nuclear envelope reassembly (GO:0007084) | 2.83877842 |
| 106 | nuclear envelope reassembly (GO:0031468) | 2.83877842 |
| 107 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.83530683 |
| 108 | translational initiation (GO:0006413) | 2.82180668 |
| 109 | proline biosynthetic process (GO:0006561) | 2.82003364 |
| 110 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.79629132 |
| 111 | oxidative phosphorylation (GO:0006119) | 2.79266824 |
| 112 | * DNA catabolic process, exonucleolytic (GO:0000738) | 2.78875513 |
| 113 | cell cycle G1/S phase transition (GO:0044843) | 2.78638874 |
| 114 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.78638874 |
| 115 | IMP metabolic process (GO:0046040) | 2.78059541 |
| 116 | maturation of 5.8S rRNA (GO:0000460) | 2.77810883 |
| 117 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.77224774 |
| 118 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.76788564 |
| 119 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.76693018 |
| 120 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.76693018 |
| 121 | tRNA methylation (GO:0030488) | 2.76347096 |
| 122 | regulation of ligase activity (GO:0051340) | 2.75687614 |
| 123 | transcription from mitochondrial promoter (GO:0006390) | 2.75436493 |
| 124 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.75382948 |
| 125 | translational elongation (GO:0006414) | 2.75346770 |
| 126 | DNA deamination (GO:0045006) | 2.74450024 |
| 127 | rRNA processing (GO:0006364) | 2.73769944 |
| 128 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.73499001 |
| 129 | Golgi transport vesicle coating (GO:0048200) | 2.72717716 |
| 130 | COPI coating of Golgi vesicle (GO:0048205) | 2.72717716 |
| 131 | regulation of sister chromatid segregation (GO:0033045) | 2.71724241 |
| 132 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.71724241 |
| 133 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.71724241 |
| 134 | replication fork processing (GO:0031297) | 2.70606958 |
| 135 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.69668508 |
| 136 | pore complex assembly (GO:0046931) | 2.68978542 |
| 137 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.68488339 |
| 138 | sister chromatid segregation (GO:0000819) | 2.68427206 |
| 139 | GDP-mannose metabolic process (GO:0019673) | 2.67924345 |
| 140 | ATP-dependent chromatin remodeling (GO:0043044) | 2.67208039 |
| 141 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.66443230 |
| 142 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.66443230 |
| 143 | cellular component biogenesis (GO:0044085) | 2.65707333 |
| 144 | rRNA metabolic process (GO:0016072) | 2.65105945 |
| 145 | tRNA aminoacylation for protein translation (GO:0006418) | 2.64963825 |
| 146 | mitochondrial RNA metabolic process (GO:0000959) | 2.64379599 |
| 147 | * base-excision repair (GO:0006284) | 2.62676821 |
| 148 | RNA splicing, via transesterification reactions (GO:0000375) | 2.62508902 |
| 149 | regulation of DNA damage checkpoint (GO:2000001) | 2.62420791 |
| 150 | regulation of DNA-dependent DNA replication (GO:0090329) | 2.62283728 |
| 151 | histone mRNA metabolic process (GO:0008334) | 2.61798303 |
| 152 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.61152641 |
| 153 | tRNA aminoacylation (GO:0043039) | 2.60829461 |
| 154 | amino acid activation (GO:0043038) | 2.60829461 |
| 155 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.60824000 |
| 156 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.60786979 |
| 157 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.60786979 |
| 158 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.60104485 |
| 159 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.59813428 |
| 160 | regulation of translational fidelity (GO:0006450) | 2.58242705 |
| 161 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.58107735 |
| 162 | folic acid metabolic process (GO:0046655) | 2.57864152 |
| 163 | rRNA methylation (GO:0031167) | 2.57849882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.82042901 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.29348478 |
| 3 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.16836807 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.98452834 |
| 5 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.64217517 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.57127289 |
| 7 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.05497957 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.86491873 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.82295049 |
| 10 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.80406615 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.78644024 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.75278443 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.68732577 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.66808052 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.64635112 |
| 16 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.58368514 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.55337566 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.44864466 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.40847493 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.31529624 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.30189134 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.26464468 |
| 23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.24286270 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.22176621 |
| 25 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.22124900 |
| 26 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.20881820 |
| 27 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.20312070 |
| 28 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.17909914 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.17439474 |
| 30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.13258766 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.11106956 |
| 32 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.02242588 |
| 33 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.00860096 |
| 34 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.96202419 |
| 35 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.93360664 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91270087 |
| 37 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.90166087 |
| 38 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.86271199 |
| 39 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.83353422 |
| 40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.82126488 |
| 41 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.77430967 |
| 42 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.77110488 |
| 43 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.77037776 |
| 44 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.76790870 |
| 45 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.76735370 |
| 46 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.74841617 |
| 47 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.74479611 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70702339 |
| 49 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.68451828 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68230293 |
| 51 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66718790 |
| 52 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.65006612 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.55431365 |
| 54 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.54041701 |
| 55 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.53202185 |
| 56 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.51555909 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48689428 |
| 58 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.47613391 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.44612166 |
| 60 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.42981514 |
| 61 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.39745167 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38392732 |
| 63 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.34327235 |
| 64 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33875724 |
| 65 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31975394 |
| 66 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.29521869 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29234563 |
| 68 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28158714 |
| 69 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.25684271 |
| 70 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24377644 |
| 71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23633267 |
| 72 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21908233 |
| 73 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.21440113 |
| 74 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21313615 |
| 75 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20462135 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19242242 |
| 77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.17753595 |
| 78 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.17222012 |
| 79 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16073139 |
| 80 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.13803289 |
| 81 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.10855777 |
| 82 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.10625279 |
| 83 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.08619286 |
| 84 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07166980 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06993703 |
| 86 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06585714 |
| 87 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06538653 |
| 88 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05805108 |
| 89 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.03651222 |
| 90 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03394357 |
| 91 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99651721 |
| 92 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.97701818 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97106269 |
| 94 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96037782 |
| 95 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.95978841 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95843688 |
| 97 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.95836255 |
| 98 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.93767107 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93727093 |
| 100 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.91658586 |
| 101 | MYC_22102868_ChIP-Seq_BL_Human | 0.91581911 |
| 102 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.89312292 |
| 103 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89076112 |
| 104 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88246020 |
| 105 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.87886763 |
| 106 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.87232541 |
| 107 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.86170827 |
| 108 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.83832342 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.83194604 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83104802 |
| 111 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82944388 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.81995379 |
| 113 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.81192719 |
| 114 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.77396412 |
| 115 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.77391240 |
| 116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.77363149 |
| 117 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.76741632 |
| 118 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.75399191 |
| 119 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.74607124 |
| 120 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.72968868 |
| 121 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.71888300 |
| 122 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.68332320 |
| 123 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.68118789 |
| 124 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.67673360 |
| 125 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.66783420 |
| 126 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.65551393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.64718013 |
| 2 | MP0003111_abnormal_nucleus_morphology | 3.72219734 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.71805284 |
| 4 | MP0008057_abnormal_DNA_replication | 3.51702196 |
| 5 | MP0006292_abnormal_olfactory_placode | 3.46958183 |
| 6 | MP0008058_abnormal_DNA_repair | 3.44428095 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.36173537 |
| 8 | MP0003077_abnormal_cell_cycle | 3.18456469 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 2.73442661 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.49190393 |
| 11 | MP0008932_abnormal_embryonic_tissue | 2.26573890 |
| 12 | MP0009697_abnormal_copulation | 2.11625564 |
| 13 | MP0002102_abnormal_ear_morphology | 2.07533226 |
| 14 | MP0003186_abnormal_redox_activity | 1.93119227 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 1.92678515 |
| 16 | MP0000566_synostosis | 1.92277797 |
| 17 | MP0005058_abnormal_lysosome_morphology | 1.88688749 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 1.78117352 |
| 19 | MP0010030_abnormal_orbit_morphology | 1.73588208 |
| 20 | MP0001188_hyperpigmentation | 1.71746076 |
| 21 | MP0003890_abnormal_embryonic-extraembry | 1.70533165 |
| 22 | MP0001853_heart_inflammation | 1.70379975 |
| 23 | MP0006035_abnormal_mitochondrial_morpho | 1.70366009 |
| 24 | MP0002396_abnormal_hematopoietic_system | 1.69624711 |
| 25 | MP0000490_abnormal_crypts_of | 1.69590916 |
| 26 | MP0003786_premature_aging | 1.66549658 |
| 27 | MP0000350_abnormal_cell_proliferation | 1.66548883 |
| 28 | MP0003121_genomic_imprinting | 1.65042985 |
| 29 | MP0005451_abnormal_body_composition | 1.64438772 |
| 30 | MP0005501_abnormal_skin_physiology | 1.63306658 |
| 31 | MP0001293_anophthalmia | 1.57793253 |
| 32 | MP0002796_impaired_skin_barrier | 1.53703632 |
| 33 | MP0003718_maternal_effect | 1.50946998 |
| 34 | MP0000358_abnormal_cell_content/ | 1.50704306 |
| 35 | MP0002938_white_spotting | 1.49163780 |
| 36 | MP0002132_abnormal_respiratory_system | 1.45850805 |
| 37 | MP0009053_abnormal_anal_canal | 1.42877537 |
| 38 | MP0003123_paternal_imprinting | 1.41134053 |
| 39 | MP0005380_embryogenesis_phenotype | 1.39859218 |
| 40 | MP0001672_abnormal_embryogenesis/_devel | 1.39859218 |
| 41 | MP0000049_abnormal_middle_ear | 1.37161497 |
| 42 | MP0004147_increased_porphyrin_level | 1.35740816 |
| 43 | MP0010234_abnormal_vibrissa_follicle | 1.32157000 |
| 44 | MP0001730_embryonic_growth_arrest | 1.30492311 |
| 45 | MP0003122_maternal_imprinting | 1.30472883 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.27391115 |
| 47 | MP0009840_abnormal_foam_cell | 1.26359703 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.26349564 |
| 49 | MP0003941_abnormal_skin_development | 1.24791164 |
| 50 | MP0002085_abnormal_embryonic_tissue | 1.23820427 |
| 51 | MP0003937_abnormal_limbs/digits/tail_de | 1.23353625 |
| 52 | MP0001697_abnormal_embryo_size | 1.20475023 |
| 53 | MP0002088_abnormal_embryonic_growth/wei | 1.18076495 |
| 54 | MP0003984_embryonic_growth_retardation | 1.17357037 |
| 55 | MP0005257_abnormal_intraocular_pressure | 1.16169433 |
| 56 | MP0003315_abnormal_perineum_morphology | 1.13808903 |
| 57 | MP0008789_abnormal_olfactory_epithelium | 1.13787285 |
| 58 | MP0005083_abnormal_biliary_tract | 1.13776710 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.12932395 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.12825659 |
| 61 | * MP0000313_abnormal_cell_death | 1.11630710 |
| 62 | MP0008877_abnormal_DNA_methylation | 1.11240553 |
| 63 | MP0010307_abnormal_tumor_latency | 1.10456015 |
| 64 | MP0004233_abnormal_muscle_weight | 1.08365516 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.07090699 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.06703793 |
| 67 | MP0001216_abnormal_epidermal_layer | 1.06448103 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.06322612 |
| 69 | MP0003567_abnormal_fetal_cardiomyocyte | 1.05680698 |
| 70 | MP0002080_prenatal_lethality | 1.04891876 |
| 71 | MP0004197_abnormal_fetal_growth/weight/ | 1.04406862 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.04359270 |
| 73 | MP0001286_abnormal_eye_development | 1.03970951 |
| 74 | MP0001119_abnormal_female_reproductive | 1.03820885 |
| 75 | MP0002084_abnormal_developmental_patter | 1.03378992 |
| 76 | MP0001873_stomach_inflammation | 1.03080417 |
| 77 | MP0000858_altered_metastatic_potential | 1.02653910 |
| 78 | MP0002019_abnormal_tumor_incidence | 1.01042078 |
| 79 | MP0001881_abnormal_mammary_gland | 1.00529714 |
| 80 | MP0002160_abnormal_reproductive_system | 1.00163112 |
| 81 | * MP0009672_abnormal_birth_weight | 0.99987462 |
| 82 | MP0002751_abnormal_autonomic_nervous | 0.99413847 |
| 83 | MP0010352_gastrointestinal_tract_polyps | 0.99356569 |
| 84 | MP0002111_abnormal_tail_morphology | 0.98356066 |
| 85 | MP0003385_abnormal_body_wall | 0.98177365 |
| 86 | MP0002163_abnormal_gland_morphology | 0.97628566 |
| 87 | MP0003755_abnormal_palate_morphology | 0.96950266 |
| 88 | * MP0009333_abnormal_splenocyte_physiolog | 0.96866420 |
| 89 | MP0001661_extended_life_span | 0.95547508 |
| 90 | MP0002148_abnormal_hypersensitivity_rea | 0.94042717 |
| 91 | * MP0009703_decreased_birth_body | 0.93898072 |
| 92 | MP0000428_abnormal_craniofacial_morphol | 0.93601402 |
| 93 | MP0003119_abnormal_digestive_system | 0.93346070 |
| 94 | MP0002722_abnormal_immune_system | 0.92954748 |
| 95 | MP0001849_ear_inflammation | 0.92555154 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.92240813 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.91730177 |
| 98 | MP0002254_reproductive_system_inflammat | 0.91538031 |
| 99 | MP0003763_abnormal_thymus_physiology | 0.91515421 |
| 100 | MP0005384_cellular_phenotype | 0.91123836 |
| 101 | MP0002210_abnormal_sex_determination | 0.90506911 |
| 102 | MP0002932_abnormal_joint_morphology | 0.90035857 |
| 103 | MP0002127_abnormal_cardiovascular_syste | 0.89691212 |
| 104 | MP0001727_abnormal_embryo_implantation | 0.89549237 |
| 105 | MP0002177_abnormal_outer_ear | 0.89213290 |
| 106 | * MP0000703_abnormal_thymus_morphology | 0.88905158 |
| 107 | MP0009379_abnormal_foot_pigmentation | 0.88775331 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.88753850 |
| 109 | MP0002249_abnormal_larynx_morphology | 0.87389378 |
| 110 | MP0003136_yellow_coat_color | 0.86899996 |
| 111 | * MP0002429_abnormal_blood_cell | 0.86034057 |
| 112 | MP0005503_abnormal_tendon_morphology | 0.85958577 |
| 113 | MP0000689_abnormal_spleen_morphology | 0.85469808 |
| 114 | MP0003935_abnormal_craniofacial_develop | 0.85424265 |
| 115 | MP0002086_abnormal_extraembryonic_tissu | 0.85327274 |
| 116 | MP0005389_reproductive_system_phenotype | 0.84719830 |
| 117 | MP0005621_abnormal_cell_physiology | 0.84509600 |
| 118 | MP0000685_abnormal_immune_system | 0.83048286 |
| 119 | MP0004133_heterotaxia | 0.83028163 |
| 120 | MP0009250_abnormal_appendicular_skeleto | 0.82676976 |
| 121 | MP0003938_abnormal_ear_development | 0.81493713 |
| 122 | MP0002139_abnormal_hepatobiliary_system | 0.81140181 |
| 123 | MP0000432_abnormal_head_morphology | 0.79802026 |
| 124 | MP0003942_abnormal_urinary_system | 0.79483646 |
| 125 | MP0005174_abnormal_tail_pigmentation | 0.77357219 |
| 126 | * MP0002398_abnormal_bone_marrow | 0.77278881 |
| 127 | MP0001764_abnormal_homeostasis | 0.77030074 |
| 128 | MP0002697_abnormal_eye_size | 0.76686026 |
| 129 | MP0002060_abnormal_skin_morphology | 0.76674787 |
| 130 | MP0002116_abnormal_craniofacial_bone | 0.76297374 |
| 131 | MP0009931_abnormal_skin_appearance | 0.75950340 |
| 132 | MP0001835_abnormal_antigen_presentation | 0.75552136 |
| 133 | MP0004264_abnormal_extraembryonic_tissu | 0.75512868 |
| 134 | MP0005464_abnormal_platelet_physiology | 0.73896293 |
| 135 | MP0004947_skin_inflammation | 0.73199097 |
| 136 | MP0002109_abnormal_limb_morphology | 0.72789687 |
| 137 | MP0001145_abnormal_male_reproductive | 0.72664255 |
| 138 | MP0000609_abnormal_liver_physiology | 0.72424947 |
| 139 | MP0000613_abnormal_salivary_gland | 0.72256355 |
| 140 | MP0005394_taste/olfaction_phenotype | 0.71561466 |
| 141 | MP0005499_abnormal_olfactory_system | 0.71561466 |
| 142 | MP0002282_abnormal_trachea_morphology | 0.71176621 |
| 143 | MP0002006_tumorigenesis | 0.70602673 |
| 144 | MP0003950_abnormal_plasma_membrane | 0.70134863 |
| 145 | MP0008260_abnormal_autophagy | 0.70131709 |
| 146 | MP0005408_hypopigmentation | 0.70073129 |
| 147 | MP0009278_abnormal_bone_marrow | 0.67840939 |
| 148 | MP0009785_altered_susceptibility_to | 0.67584389 |
| 149 | MP0000627_abnormal_mammary_gland | 0.67516300 |
| 150 | MP0008469_abnormal_protein_level | 0.67359338 |
| 151 | MP0005397_hematopoietic_system_phenotyp | 0.67156929 |
| 152 | MP0001545_abnormal_hematopoietic_system | 0.67156929 |
| 153 | MP0005319_abnormal_enzyme/_coenzyme | 0.67103894 |
| 154 | MP0001879_abnormal_lymphatic_vessel | 0.67021683 |
| 155 | MP0005330_cardiomyopathy | 0.66839646 |
| 156 | MP0002233_abnormal_nose_morphology | 0.66167155 |
| 157 | MP0000598_abnormal_liver_morphology | 0.65493227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.94053206 |
| 2 | Chromsome breakage (HP:0040012) | 4.86793888 |
| 3 | Reticulocytopenia (HP:0001896) | 4.24054661 |
| 4 | Birth length less than 3rd percentile (HP:0003561) | 3.87891067 |
| 5 | Meckel diverticulum (HP:0002245) | 3.58790668 |
| 6 | Abnormality of the ileum (HP:0001549) | 3.43879840 |
| 7 | Abnormal number of incisors (HP:0011064) | 3.34828481 |
| 8 | Abnormal gallbladder physiology (HP:0012438) | 3.33671132 |
| 9 | Cholecystitis (HP:0001082) | 3.33671132 |
| 10 | Abnormality of glycolysis (HP:0004366) | 3.26602018 |
| 11 | Impulsivity (HP:0100710) | 3.26439475 |
| 12 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.25725889 |
| 13 | Patellar aplasia (HP:0006443) | 3.21308991 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.20807275 |
| 15 | Abnormality of chromosome stability (HP:0003220) | 3.19394609 |
| 16 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.17342001 |
| 17 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.15681707 |
| 18 | Ragged-red muscle fibers (HP:0003200) | 3.13402158 |
| 19 | Ectopic kidney (HP:0000086) | 3.13394160 |
| 20 | Increased serum pyruvate (HP:0003542) | 3.12981593 |
| 21 | Progressive muscle weakness (HP:0003323) | 3.12149472 |
| 22 | Abnormality of the preputium (HP:0100587) | 3.03999737 |
| 23 | Hepatic necrosis (HP:0002605) | 3.00576621 |
| 24 | Acute necrotizing encephalopathy (HP:0006965) | 2.99537055 |
| 25 | Increased CSF lactate (HP:0002490) | 2.97614447 |
| 26 | Acute encephalopathy (HP:0006846) | 2.89623232 |
| 27 | Mitochondrial inheritance (HP:0001427) | 2.86611281 |
| 28 | Testicular atrophy (HP:0000029) | 2.84822824 |
| 29 | Increased serum lactate (HP:0002151) | 2.83514742 |
| 30 | Abnormal protein glycosylation (HP:0012346) | 2.77754454 |
| 31 | Abnormal glycosylation (HP:0012345) | 2.77754454 |
| 32 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.77754454 |
| 33 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.77754454 |
| 34 | Sparse eyelashes (HP:0000653) | 2.77330203 |
| 35 | Multiple enchondromatosis (HP:0005701) | 2.76344318 |
| 36 | Reduced antithrombin III activity (HP:0001976) | 2.71172180 |
| 37 | Breast hypoplasia (HP:0003187) | 2.70812665 |
| 38 | Triphalangeal thumb (HP:0001199) | 2.68849243 |
| 39 | Trismus (HP:0000211) | 2.66931015 |
| 40 | Abnormal trabecular bone morphology (HP:0100671) | 2.65825681 |
| 41 | Absent radius (HP:0003974) | 2.61591852 |
| 42 | Petechiae (HP:0000967) | 2.56082523 |
| 43 | Facial cleft (HP:0002006) | 2.55498846 |
| 44 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.54713501 |
| 45 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.54713501 |
| 46 | Duplicated collecting system (HP:0000081) | 2.53362434 |
| 47 | Pallor (HP:0000980) | 2.49900090 |
| 48 | Abnormality of DNA repair (HP:0003254) | 2.49880154 |
| 49 | Small intestinal stenosis (HP:0012848) | 2.46609582 |
| 50 | Duodenal stenosis (HP:0100867) | 2.46609582 |
| 51 | Concave nail (HP:0001598) | 2.45433163 |
| 52 | Abnormality of the umbilical cord (HP:0010881) | 2.44680776 |
| 53 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.44280574 |
| 54 | Abnormality of the renal collecting system (HP:0004742) | 2.43141702 |
| 55 | Lactic acidosis (HP:0003128) | 2.41751739 |
| 56 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.41225730 |
| 57 | Absent thumb (HP:0009777) | 2.39707175 |
| 58 | Squamous cell carcinoma (HP:0002860) | 2.39340024 |
| 59 | Cerebral edema (HP:0002181) | 2.36927389 |
| 60 | Horseshoe kidney (HP:0000085) | 2.35813557 |
| 61 | Aplasia involving forearm bones (HP:0009822) | 2.34704307 |
| 62 | Absent forearm bone (HP:0003953) | 2.34704307 |
| 63 | Microvesicular hepatic steatosis (HP:0001414) | 2.32471140 |
| 64 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.31774836 |
| 65 | Single umbilical artery (HP:0001195) | 2.31774836 |
| 66 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.31774836 |
| 67 | Myelodysplasia (HP:0002863) | 2.30813251 |
| 68 | Hypokinesia (HP:0002375) | 2.27790538 |
| 69 | Abnormality of the carotid arteries (HP:0005344) | 2.26313304 |
| 70 | Optic nerve coloboma (HP:0000588) | 2.25511068 |
| 71 | Exercise intolerance (HP:0003546) | 2.25167906 |
| 72 | Bone marrow hypocellularity (HP:0005528) | 2.25101281 |
| 73 | Macrocytic anemia (HP:0001972) | 2.23725210 |
| 74 | Abnormality of abdominal situs (HP:0011620) | 2.23561924 |
| 75 | Abdominal situs inversus (HP:0003363) | 2.23561924 |
| 76 | Microretrognathia (HP:0000308) | 2.23053547 |
| 77 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.22175867 |
| 78 | Pancytopenia (HP:0001876) | 2.21874516 |
| 79 | Secondary amenorrhea (HP:0000869) | 2.16638870 |
| 80 | Premature graying of hair (HP:0002216) | 2.15934576 |
| 81 | Progressive macrocephaly (HP:0004481) | 2.14936424 |
| 82 | Increased hepatocellular lipid droplets (HP:0006565) | 2.13959443 |
| 83 | Clubbing of toes (HP:0100760) | 2.13767528 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.13707913 |
| 85 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.12283247 |
| 86 | Entropion (HP:0000621) | 2.11992795 |
| 87 | Tracheoesophageal fistula (HP:0002575) | 2.11785216 |
| 88 | Abnormality of the labia minora (HP:0012880) | 2.09908339 |
| 89 | Rough bone trabeculation (HP:0100670) | 2.07537765 |
| 90 | Selective tooth agenesis (HP:0001592) | 2.06863125 |
| 91 | Short middle phalanx of the 5th finger (HP:0004220) | 2.06733744 |
| 92 | Abnormality of the duodenum (HP:0002246) | 2.06471912 |
| 93 | Agnosia (HP:0010524) | 2.05927997 |
| 94 | Short thumb (HP:0009778) | 2.05733331 |
| 95 | Renal Fanconi syndrome (HP:0001994) | 2.05722192 |
| 96 | Rhabdomyosarcoma (HP:0002859) | 2.05596891 |
| 97 | Sloping forehead (HP:0000340) | 2.05424471 |
| 98 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.04920065 |
| 99 | Hypertensive crisis (HP:0100735) | 2.04735861 |
| 100 | Pancreatic fibrosis (HP:0100732) | 2.03024961 |
| 101 | Respiratory failure (HP:0002878) | 2.02894824 |
| 102 | Abnormality of the incisor (HP:0000676) | 2.00543367 |
| 103 | Abnormal number of erythroid precursors (HP:0012131) | 2.00435430 |
| 104 | Oral leukoplakia (HP:0002745) | 1.99980051 |
| 105 | Increased intramyocellular lipid droplets (HP:0012240) | 1.99847816 |
| 106 | Ileus (HP:0002595) | 1.99000828 |
| 107 | Abnormality of reticulocytes (HP:0004312) | 1.98928484 |
| 108 | Aplastic anemia (HP:0001915) | 1.98771996 |
| 109 | Atresia of the external auditory canal (HP:0000413) | 1.98399230 |
| 110 | Embryonal renal neoplasm (HP:0011794) | 1.97356297 |
| 111 | Duplication of thumb phalanx (HP:0009942) | 1.97299894 |
| 112 | Preaxial hand polydactyly (HP:0001177) | 1.95494152 |
| 113 | Medulloblastoma (HP:0002885) | 1.94635194 |
| 114 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.94243913 |
| 115 | Supernumerary spleens (HP:0009799) | 1.93796103 |
| 116 | Median cleft lip (HP:0000161) | 1.92310732 |
| 117 | Progressive external ophthalmoplegia (HP:0000590) | 1.91619280 |
| 118 | Poikiloderma (HP:0001029) | 1.91547675 |
| 119 | Lipid accumulation in hepatocytes (HP:0006561) | 1.91154587 |
| 120 | Abnormal lung lobation (HP:0002101) | 1.89563595 |
| 121 | Cleft eyelid (HP:0000625) | 1.89055445 |
| 122 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.87428754 |
| 123 | Respiratory difficulties (HP:0002880) | 1.85827397 |
| 124 | Abnormality of the fingertips (HP:0001211) | 1.85144427 |
| 125 | Cellular immunodeficiency (HP:0005374) | 1.84113280 |
| 126 | Cholelithiasis (HP:0001081) | 1.83820382 |
| 127 | Prostate neoplasm (HP:0100787) | 1.83427846 |
| 128 | Flat capital femoral epiphysis (HP:0003370) | 1.83046245 |
| 129 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.82585304 |
| 130 | Congenital, generalized hypertrichosis (HP:0004540) | 1.81030232 |
| 131 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.80345472 |
| 132 | Abnormality of the anterior horn cell (HP:0006802) | 1.79911469 |
| 133 | Degeneration of anterior horn cells (HP:0002398) | 1.79911469 |
| 134 | Hypergonadotropic hypogonadism (HP:0000815) | 1.78697488 |
| 135 | Increased muscle lipid content (HP:0009058) | 1.77710230 |
| 136 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.76537429 |
| 137 | Intestinal fistula (HP:0100819) | 1.75892029 |
| 138 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.75745391 |
| 139 | Neoplasm of the pancreas (HP:0002894) | 1.74675404 |
| 140 | Proximal placement of thumb (HP:0009623) | 1.73861920 |
| 141 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.73044245 |
| 142 | Neoplasm of striated muscle (HP:0009728) | 1.72828285 |
| 143 | Short 4th metacarpal (HP:0010044) | 1.72643372 |
| 144 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.72643372 |
| 145 | Upper limb muscle weakness (HP:0003484) | 1.72597178 |
| 146 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.72131157 |
| 147 | Carpal bone hypoplasia (HP:0001498) | 1.69630703 |
| 148 | Ependymoma (HP:0002888) | 1.69282777 |
| 149 | Septate vagina (HP:0001153) | 1.69005239 |
| 150 | Shawl scrotum (HP:0000049) | 1.68990774 |
| 151 | Mesomelia (HP:0003027) | 1.68102264 |
| 152 | Nausea (HP:0002018) | 1.67968045 |
| 153 | Reticulocytosis (HP:0001923) | 1.67496154 |
| 154 | Abnormal gallbladder morphology (HP:0012437) | 1.67088275 |
| 155 | Abnormality of the metopic suture (HP:0005556) | 1.66929356 |
| 156 | Adrenal hypoplasia (HP:0000835) | 1.65595936 |
| 157 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.65475697 |
| 158 | Increased serum ferritin (HP:0003281) | 1.65042347 |
| 159 | Rectal fistula (HP:0100590) | 1.65018475 |
| 160 | Rectovaginal fistula (HP:0000143) | 1.65018475 |
| 161 | Paralysis (HP:0003470) | 1.64165491 |
| 162 | Fasciculations (HP:0002380) | 1.63899651 |
| 163 | Midline defect of the nose (HP:0004122) | 1.63132923 |
| 164 | Submucous cleft hard palate (HP:0000176) | 1.62074991 |
| 165 | Bifid tongue (HP:0010297) | 1.61064148 |
| 166 | Prominent nose (HP:0000448) | 1.60540608 |
| 167 | Congenital hepatic fibrosis (HP:0002612) | 1.59538556 |
| 168 | Pancreatic cysts (HP:0001737) | 1.59524211 |
| 169 | Type I transferrin isoform profile (HP:0003642) | 1.59429112 |
| 170 | Increased number of teeth (HP:0011069) | 1.57402789 |
| 171 | Abnormality of the intervertebral disk (HP:0005108) | 1.56073513 |
| 172 | Premature ovarian failure (HP:0008209) | 1.54434578 |
| 173 | Long eyelashes (HP:0000527) | 1.53518990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 4.71273721 |
| 2 | VRK2 | 4.12892730 |
| 3 | SRPK1 | 3.73164998 |
| 4 | BUB1 | 2.86520587 |
| 5 | CDC7 | 2.67258981 |
| 6 | INSRR | 2.56001184 |
| 7 | STK16 | 2.54008149 |
| 8 | WEE1 | 2.45680606 |
| 9 | SMG1 | 2.42531593 |
| 10 | MKNK2 | 2.29090693 |
| 11 | MKNK1 | 2.29083242 |
| 12 | EIF2AK1 | 2.26855940 |
| 13 | PLK4 | 2.22894002 |
| 14 | NEK1 | 2.07521797 |
| 15 | ZAK | 1.99154854 |
| 16 | AKT3 | 1.97609649 |
| 17 | MST4 | 1.94907046 |
| 18 | TTK | 1.93964497 |
| 19 | VRK1 | 1.93495629 |
| 20 | BRSK2 | 1.86802949 |
| 21 | ATR | 1.82061095 |
| 22 | EIF2AK2 | 1.81120293 |
| 23 | CDK7 | 1.81034531 |
| 24 | PLK1 | 1.78620246 |
| 25 | DYRK3 | 1.78428493 |
| 26 | ACVR1B | 1.74311169 |
| 27 | ERN1 | 1.70177197 |
| 28 | STK38L | 1.69672903 |
| 29 | PAK4 | 1.69423364 |
| 30 | TESK1 | 1.66283642 |
| 31 | LATS1 | 1.64881953 |
| 32 | BRD4 | 1.62630392 |
| 33 | CDK12 | 1.60029008 |
| 34 | PDK2 | 1.59717704 |
| 35 | AURKB | 1.52719806 |
| 36 | RPS6KA4 | 1.50989024 |
| 37 | NME2 | 1.41104382 |
| 38 | MST1R | 1.39657230 |
| 39 | NEK2 | 1.38913212 |
| 40 | BCKDK | 1.36526237 |
| 41 | CHEK2 | 1.33726593 |
| 42 | TXK | 1.30560118 |
| 43 | PLK3 | 1.26484676 |
| 44 | YES1 | 1.25739041 |
| 45 | CDK8 | 1.23272295 |
| 46 | ARAF | 1.19018144 |
| 47 | SIK3 | 1.16484170 |
| 48 | STK4 | 1.16411996 |
| 49 | EIF2AK3 | 1.10182699 |
| 50 | SCYL2 | 1.09928127 |
| 51 | TAF1 | 1.06423352 |
| 52 | BRAF | 1.02107326 |
| 53 | PASK | 1.02081736 |
| 54 | TEC | 1.01052407 |
| 55 | TRIB3 | 1.00949954 |
| 56 | TSSK6 | 1.00514675 |
| 57 | PIM1 | 0.99504486 |
| 58 | STK3 | 0.95923785 |
| 59 | AURKA | 0.95385042 |
| 60 | ATM | 0.94568005 |
| 61 | DAPK1 | 0.93506466 |
| 62 | PBK | 0.92529923 |
| 63 | MAP3K12 | 0.92195194 |
| 64 | IRAK4 | 0.91340942 |
| 65 | CHEK1 | 0.89538478 |
| 66 | BRSK1 | 0.88219155 |
| 67 | TAOK2 | 0.87762409 |
| 68 | CDK4 | 0.85012663 |
| 69 | CASK | 0.82661005 |
| 70 | IRAK3 | 0.82474286 |
| 71 | LIMK1 | 0.81831860 |
| 72 | MAP3K8 | 0.81462446 |
| 73 | NLK | 0.80465391 |
| 74 | RPS6KA5 | 0.80009264 |
| 75 | IKBKB | 0.78353238 |
| 76 | LRRK2 | 0.78030383 |
| 77 | ILK | 0.75037751 |
| 78 | LMTK2 | 0.74838840 |
| 79 | STK10 | 0.74718159 |
| 80 | MAP3K11 | 0.73973485 |
| 81 | TGFBR1 | 0.72891375 |
| 82 | GRK1 | 0.72852201 |
| 83 | TBK1 | 0.69276461 |
| 84 | CDK2 | 0.69176282 |
| 85 | PRPF4B | 0.68898006 |
| 86 | PRKCI | 0.66785708 |
| 87 | CLK1 | 0.65045047 |
| 88 | DYRK2 | 0.64592954 |
| 89 | CSNK2A1 | 0.64383566 |
| 90 | NEK9 | 0.63410709 |
| 91 | ABL2 | 0.63172404 |
| 92 | JAK3 | 0.62972344 |
| 93 | SIK1 | 0.62563620 |
| 94 | CHUK | 0.61063372 |
| 95 | TESK2 | 0.60816297 |
| 96 | CDK1 | 0.58964242 |
| 97 | MAP3K14 | 0.57948898 |
| 98 | MAP3K3 | 0.56710180 |
| 99 | CSNK2A2 | 0.56130122 |
| 100 | TRIM28 | 0.54945522 |
| 101 | EEF2K | 0.53290631 |
| 102 | MAPKAPK3 | 0.51996546 |
| 103 | MAPK11 | 0.51684659 |
| 104 | ERBB4 | 0.51208792 |
| 105 | EPHA2 | 0.50897316 |
| 106 | IRAK2 | 0.50490798 |
| 107 | MAP2K3 | 0.49320970 |
| 108 | MELK | 0.48218716 |
| 109 | BLK | 0.47420886 |
| 110 | ALK | 0.46995659 |
| 111 | CAMK1D | 0.45428430 |
| 112 | MAPKAPK2 | 0.45405811 |
| 113 | LATS2 | 0.45189886 |
| 114 | MAP2K6 | 0.43643102 |
| 115 | IRAK1 | 0.42882778 |
| 116 | NUAK1 | 0.42184670 |
| 117 | MAP4K1 | 0.42051715 |
| 118 | ICK | 0.41948839 |
| 119 | RPS6KB2 | 0.41053923 |
| 120 | BMX | 0.40942277 |
| 121 | STK24 | 0.40881303 |
| 122 | CAMK4 | 0.40825864 |
| 123 | ERBB2 | 0.40631140 |
| 124 | MET | 0.39691843 |
| 125 | BTK | 0.38563260 |
| 126 | PRKAA2 | 0.38364464 |
| 127 | CDC42BPA | 0.38037204 |
| 128 | CDK9 | 0.37421023 |
| 129 | PIM2 | 0.36904820 |
| 130 | CSNK1G3 | 0.36441118 |
| 131 | LYN | 0.36313777 |
| 132 | CDK3 | 0.36148404 |
| 133 | WNK3 | 0.35424415 |
| 134 | PRKDC | 0.35157411 |
| 135 | AKT1 | 0.35123108 |
| 136 | DYRK1B | 0.34752953 |
| 137 | TYK2 | 0.32841776 |
| 138 | KIT | 0.31280561 |
| 139 | NME1 | 0.29576027 |
| 140 | PAK1 | 0.27575895 |
| 141 | MAPK14 | 0.27432218 |
| 142 | IKBKE | 0.26558599 |
| 143 | KDR | 0.26361199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.31658119 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.92210250 |
| 3 | Homologous recombination_Homo sapiens_hsa03440 | 3.46404806 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.39043228 |
| 5 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.38375338 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 3.22078606 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.10481112 |
| 8 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 3.08026910 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.97858822 |
| 10 | * Base excision repair_Homo sapiens_hsa03410 | 2.70634038 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 2.64056697 |
| 12 | Cell cycle_Homo sapiens_hsa04110 | 2.59553395 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.54660541 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.53774322 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.47035878 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.42808929 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 2.18916700 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.92774692 |
| 19 | RNA degradation_Homo sapiens_hsa03018 | 1.88938561 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.87130063 |
| 21 | Basal transcription factors_Homo sapiens_hsa03022 | 1.82447740 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.70471026 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68845088 |
| 24 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.63120866 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.61131071 |
| 26 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.56763524 |
| 27 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.55872954 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.46877061 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.45428922 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37857850 |
| 31 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.34562024 |
| 32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.33439423 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.29973374 |
| 34 | Purine metabolism_Homo sapiens_hsa00230 | 1.28173378 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23639979 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.19495710 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15162413 |
| 38 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.13881422 |
| 39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11691255 |
| 40 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.07250838 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03865637 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00917443 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00887417 |
| 44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99940651 |
| 45 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.98635987 |
| 46 | Protein export_Homo sapiens_hsa03060 | 0.97678947 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.84613345 |
| 48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80644469 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79673440 |
| 50 | Measles_Homo sapiens_hsa05162 | 0.79378054 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78968311 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78523566 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78328711 |
| 54 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78322070 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.76461415 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75003135 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.74624595 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74280552 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73604563 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73253094 |
| 61 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.72211318 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.70304614 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69603427 |
| 64 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.69590122 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69573487 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68841349 |
| 67 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.67176337 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66315260 |
| 69 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64396856 |
| 70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64199289 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63096530 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63079229 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.60455056 |
| 74 | Allograft rejection_Homo sapiens_hsa05330 | 0.60416834 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60055624 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59957313 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59038201 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57940281 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56520102 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55993492 |
| 81 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.54826859 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.54743058 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54533602 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51873111 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.51481364 |
| 86 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50515094 |
| 87 | Influenza A_Homo sapiens_hsa05164 | 0.50275119 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50163757 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50056115 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.49635734 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49445451 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48746904 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47528712 |
| 94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47321882 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45953461 |
| 96 | Legionellosis_Homo sapiens_hsa05134 | 0.44643422 |
| 97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44373247 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43988375 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.43343148 |
| 100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43200808 |
| 101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43074897 |
| 102 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42285862 |
| 103 | Melanoma_Homo sapiens_hsa05218 | 0.41009174 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.38765835 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38566520 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37885551 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.36878111 |
| 108 | Asthma_Homo sapiens_hsa05310 | 0.36373789 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36137125 |
| 110 | Phototransduction_Homo sapiens_hsa04744 | 0.35968892 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34550177 |
| 112 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31234277 |
| 113 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.28850527 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28151526 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.28009939 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27378289 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.26644256 |
| 118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.24993331 |
| 119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.24934344 |
| 120 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24633397 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24400054 |
| 122 | Leishmaniasis_Homo sapiens_hsa05140 | 0.24118955 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23999414 |
| 124 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.23219647 |
| 125 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.22976142 |
| 126 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.20730634 |
| 127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20451126 |
| 128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.20327177 |
| 129 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19911464 |
| 130 | Malaria_Homo sapiens_hsa05144 | 0.19290271 |
| 131 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.18499229 |
| 132 | Adherens junction_Homo sapiens_hsa04520 | 0.17340181 |
| 133 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15282046 |
| 134 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.15013394 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.14379522 |
| 136 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13066703 |
| 137 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.12837172 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10982871 |
| 139 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.10864520 |

